NCT01872221 2026-04-14
STEMRI
Institut Claudius Regaud
Phase NA Completed
Clinical Trials
73 trialsNCT04988750 2026-04-13
Evaluate the Safety and Preliminary Efficacy of the Combination of NaviFUS System With Re-irradiation for rGBM Patients
NaviFUS Corporation
Phase NA Completed
NCT04446416 2026-04-09
Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients
NaviFUS Corporation
Phase NA Completed
NCT04730869 2026-04-09
Metabolic Therapy Program In Conjunction With Standard Treatment For Glioblastoma
Waikato Hospital
Phase NA Completed
NCT04471844 2026-03-30
EF-32
NovoCure Ltd.
Phase NA Completed
NCT02286167 2026-03-24
GLAD
Wake Forest University Health Sciences
Phase NA Completed
NCT03551249 2026-03-20
Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption
InSightec
Phase NA Completed
NCT03048240 2026-02-05
INDYGO
University Hospital, Lille
Phase NA Completed
NCT05735171 2025-12-24
SupraGlio-AI
Hospital del Rio Hortega
Phase NA Completed
NCT04566185 2025-12-18
EVA DOPA
Centre Hospitalier Universitaire de Nīmes
Phase NA Completed
NCT02902757 2025-12-17
FDG PET/CT in Monitoring Very Early Therapy Response in Patients With Glioblastoma
Jonsson Comprehensive Cancer Center
Phase NA Completed
NCT03975959 2025-09-23
PROMESSE
Institut du Cancer de Montpellier - Val d'Aurelle
Phase NA Completed
NCT05383872 2025-07-28
Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors
InSightec
Phase NA Completed
NCT04734444 2025-06-17
SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue
SonoClear AS
Phase NA Completed
NCT04610229 2025-06-12
GLIORAD
Azienda USL Reggio Emilia - IRCCS
Phase NA Completed
NCT05759195 2025-03-13
RegoRec
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase NA Completed
NCT05772767 2025-03-13
RF2019-1236878
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase NA Completed
NCT05131815 2025-02-26
The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors
Cedars-Sinai Medical Center
Phase NA Completed
NCT05140902 2025-02-14
Accurate DCE-MRI Measurement of Glioblastoma Using Point-of-care Portable Perfusion Phantom
University of Alabama at Birmingham
Phase NA Completed
NCT05296122 2025-01-15
Safety and Feasibility of MR-guided Laser Thermal Ablation of Brain Lesions
Clinical Laserthermia Systems AB
Phase NA Completed
NCT05015543 2024-12-12
MMH
University Hospital Muenster
Phase NA Completed
NCT04726397 2024-11-29
UNITED
Sunnybrook Health Sciences Centre
Phase NA Completed
NCT03922984 2024-10-22
Non-Contrast Perfusion Using Arterial Spin Labeled MR Imaging for Assessment of Therapy Response in Glioblastoma
University of Texas Southwestern Medical Center
Phase NA Completed
NCT03926507 2024-10-09
F18 Fluciclovine PET/CT in Assessing Tumor Volume and Radiation Therapy Response in Patients With Glioblastoma Undergoing Surgery
M.D. Anderson Cancer Center
Phase NA Completed
NCT03278249 2024-09-19
Feasibility Study of Modified Atkins Ketogenic Diet in the Treatment of Newly Diagnosed Malignant Glioma
University of Cincinnati
Phase NA Completed
NCT01923922 2024-08-21
CT Perfusion in the Prognostication of Cerebral High Grade Glioma
Nova Scotia Health Authority
Phase NA Completed
NCT06038604 2024-07-31
Glioblastoma Psychosocial Support Program
Duke University
Phase NA Completed
NCT02441322 2024-07-19
Evaluating Therapeutic Response to Novo-TTF
Abramson Cancer Center at Penn Medicine
Phase NA Completed
NCT04604158 2024-05-21
Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients
Cedars-Sinai Medical Center
Phase NA Completed
NCT03712293 2024-03-05
ExAblate Blood-Brain Barrier Disruption for Glioblastoma in Patients Undergoing Standard Chemotherapy
InSightec
Phase NA Completed
NCT03616860 2024-01-23
Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption for Treatment of Glioma
InSightec
Phase NA Completed
NCT03557372 2023-10-26
Mathematical Model-Adapted Radiation In Glioblastoma
Dana-Farber Cancer Institute
Phase NA Completed
NCT03538587 2023-08-01
Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers
National Institutes of Health Clinical Center (CC)
Phase NA Completed
NCT05896449 2023-06-09
Predictive Values of Preoperative [68Ga]Ga-PSMA-11 PET/CT in Patients With Suspected Brain Tumours of Glial Origin
Medical University of Warsaw
Phase NA Completed
NCT04630379 2023-03-20
Early Integration of Palliative Care Using the BEACON PROQOL in Patients With High Grade Glioma and Their Caregivers
Mayo Clinic
Phase NA Completed
NCT02296580 2023-02-02
A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM)
Nativis, Inc.
Phase NA Completed
NCT03276286 2023-02-02
NAT109
Nativis, Inc.
Phase NA Completed
NCT04114786 2022-10-21
3D Printed Mask for GBM and Brain Mets
University Health Network, Toronto
Phase NA Completed
NCT04596930 2022-08-09
EMITT
Radboud University Medical Center
Phase NA Completed
NCT03390569 2022-04-14
Exercise in Patients With Glioblastoma
University Health Network, Toronto
Phase NA Completed
NCT02359097 2022-03-17
Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma
OHSU Knight Cancer Institute
Phase NA Completed
NCT04516733 2022-03-14
GLIOSUPPORT
Institut du Cancer de Montpellier - Val d'Aurelle
Phase NA Completed
NCT02379572 2021-10-22
Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas
University Hospital Tuebingen
Phase NA Completed
NCT02076152 2021-07-30
FMISO PET Study of Glioblastoma
Massachusetts General Hospital
Phase NA Completed
NCT01754350 2021-06-02
ERGO2
Johann Wolfgang Goethe University Hospital
Phase NA Completed
NCT04790097 2021-05-06
dualFETboost
Prof. Franciszek Lukaszczyk Memorial Oncology Center
Phase NA Completed
NCT00400322 2021-03-01
Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection
Karolinska Institutet
Phase NA Completed
NCT02631655 2021-02-16
POSEIDON
Centre Antoine Lacassagne
Phase NA Completed
NCT01987830 2020-09-04
Bevacizumab w / Temozolomide PET & Vascular MRI For GBM
Massachusetts General Hospital
Phase NA Completed
NCT01813877 2020-07-27
Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma
Jonsson Comprehensive Cancer Center
Phase NA Completed